Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Epanutin

- PMLiVE

Scottish cabinet reshuffle sees Alex Neil made health secretary

Moves from infrastructure, investment and cities to take over from Nicola Sturgeon

Pfizer gets US approval for leukaemia drug Bosulif

FDA grants the tyrosine kinase inhibitor a licence to treat chronic myelogenous leukaemia

- PMLiVE

Pfizer’s Inlyta gets EU approval for advanced kidney cancer

Available as second-line therapy after treatment with pharma firm's own Sutent

Jeremy Hunt replaces Andrew Lansley as UK Health Secretary

Will take over implementation of NHS reforms and efficiency savings

- PMLiVE

UK sets up digital innovation fund to improve patient care

NHS fund will also support new services that help share healthcare information

- PMLiVE

UK pharma ‘must prove value’ to the NHS

Facing unprecedented financial pressures, it is imperative companies continue to evolve

- PMLiVE

Pfizer dealt another blow as Torisel fails kidney cancer trial

Results are another setback in company's bid to extend the indications for its mTOR inhibitor

- PMLiVE

New cancer drugs safer for patients, says study

NHS and research charity sees huge benefits in targeted cancer therapies

- PMLiVE

End of the line for intravenous bapineuzumab in Alzheimer’s

Negative trial results for Pfizer and Johnson & Johnson to concede defeat

- PMLiVE

Pfizer sells Kent R&D centre to property consortium

Discovery Park Ltd takes over site 18 months after US pharma firm announced plans to exit it

- PMLiVE

Interview: Deepak Khanna, ABPI

Collaboration, communication and an appropriate drug pricing scheme are key says ABPI president

- PMLiVE

Major NHS prescription data changes on the way for UK pharma

Webinar will examine the challenges in the UK's forthcoming information revolution

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links